Moreover, the addition of metformin at an anti-diabetes dose resulted in a significant increase in the levels of p-AKT and p-mTOR in local diabetes wounds, therefore promoting the angiogenic potential of BMSCs (Du et al., 2023). The gene discussed is AKT1; the disease is diabetes mellitus.